BioregulatorResearch
Visoluten
Also known as: Retinal Extract Bioregulator
A Cytomax retinal bioregulator for preserving visual acuity and defending against glaucoma and age-related macular degeneration.
Reviewed by Dr. Sarah Mitchell, PharmD, BCPS
Lead Researcher · 12+ years in peptide therapeutics
Half-Life
~30 minutes
Typical Dose
Per bioregulator protocol
Administration
Oral capsule
Mechanism of Action
Retinal-derived peptide complex that halts photoreceptor degeneration and supports optic nerve health.
Key Research Areas
bioregulatorretinavisionglaucoma
Frequently Asked Questions
What is Visoluten?▾
A Cytomax retinal bioregulator for preserving visual acuity and defending against glaucoma and age-related macular degeneration.
How does Visoluten work?▾
Retinal-derived peptide complex that halts photoreceptor degeneration and supports optic nerve health.
What is the recommended dosage for Visoluten?▾
The typical research dosage is Per bioregulator protocol, administered via Oral capsule. Dosage protocols vary by study and should be determined by a qualified healthcare professional.
What is the half-life of Visoluten?▾
The half-life of Visoluten is approximately ~30 minutes. This affects dosing frequency and timing in research protocols.
Is Visoluten FDA approved?▾
Visoluten is currently classified as "Research" and is not FDA approved for general use. It is available for research purposes or through compounding pharmacies depending on your jurisdiction.
Research Disclaimer
The information provided about Visoluten is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.